Exploring Strides Made in Ovarian Cancer & STS in Stanford

Published: Wednesday, Dec 19, 2018

On October 25th, we visited Stanford, California, for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma. At the meeting, faculty from Stanford Medicine discussed advances made in the treatment landscapes, touching on available modalities, such as immunotherapy, antibody drug conjugates, and PARP inhibitors.
View Conference Coverage
Online CME Activities
Publication Bottom Border
Border Publication